Latest News-TERUMO CORPORATION Mediaroom_Page

Terumo Establishes Corporate Venture Capital "Terumo Ventures"

TOKYO, Aug. 6, 2024 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has esta...

2024-08-06 09:00 2581

FDA Clears the Individualized Nomogram for Rika Plasma Donation System

The latest innovation is anticipated to increase collection volume without increasing collection ti...

2024-05-09 20:00 1374

FDA Clears the Individualized Nomogram for Rika Plasma Donation System

Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Reveos is positioned to help U.S. blood centers supplement the platelet supply, reduce labor and co...

2023-08-01 20:30 1518

Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA

IMUGARD to Help Strained U.S. Platelet Supply Meet Growing Need LAKEWOOD, Colo., Feb. 16, 2023 /PRN...

2023-02-17 03:48 2009

Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA

New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography

– Researchers used Terumo Health Outcomes' ePRISM® software to calculate safe contrast volume targ...

2022-11-01 20:00 1470

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Adjunctive use of Blood Glucose Meter Principally Not Required TOKYO, May 16, 2022 /PRNewswire/ -- ...

2022-05-16 15:19 3589

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing

A Technology Integration for MEDISAFE WITHTM Insulin Patch Pump Patients to Upload Data Anytime Any...

2022-03-30 15:00 4136

Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing

Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive Culture

TOKYO, Mar. 1, 2022 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has esta...

2022-03-01 09:00 2081

Terumo and Corazon Sign Collaboration and Co-Marketing Agreement

SOMERSET, N.J., Feb. 25, 2022 /PRNewswire/ -- Terumo Health Outcomes, a division of Terumo Medical ...

2022-02-25 22:00 3507

Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A

SOMERSET, N.J., Jan. 11, 2022 /PRNewswire/ -- Terumo Medical Corporation (TMC) applauds the publica...

2022-01-12 03:40 2112

Terumo Corporation and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings

TOKYO and PARIS, Nov. 17, 2021 /PRNewswire/ -- Terumo Corporation, a global leader in medical techn...

2021-11-17 16:00 1933

Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe

* The therapy aims to re-energize a patient's immune system to fight cancer tumors * Initial co...

2021-11-17 00:00 1648

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare

TOKYO, Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical ...

2021-09-17 15:30 3217

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy

1 in 3 people will be diagnosed with cancer in their lifetime1 LAKEWOOD, Colo. and FORT COLLINS, Co...

2021-08-11 23:00 21820

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy

Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology

LEUVEN, Belgium, July 20, 2021 /PRNewswire/ -- Terumo Europe and University Medical Center Utrecht ...

2021-07-20 22:54 12685

Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology

Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System

SOMERSET, N.J., July 14, 2021 /PRNewswire/ -- Terumo Medical Corporation (TMC) has announced today ...

2021-07-14 20:00 30642

Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO

TOKYO, May 14, 2021 /PRNewswire/ -- As the world joins together to fight the ongoing battle against...

2021-05-14 09:05 6046

Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform

LAKEWOOD, Colo. and BOCA RATON, Fla., April 19, 2021 /PRNewswire/ -- Terumo Blood and Cell Techno...

2021-04-20 05:00 2293

Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients

LEUVEN, Belgium, April 12, 2021 /PRNewswire/ -- Terumo is proud to announce the launch of its Globa...

2021-04-12 22:25 3207

Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.

TOKYO, Feb. 23, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical tec...

2021-02-24 07:00 8516